nodes	percent_of_prediction	percent_of_DWPC	metapath
Acamprosate—GRIN3B—testis—testicular cancer	0.0079	0.196	CbGeAlD
Acamprosate—GRM5—testis—testicular cancer	0.00498	0.124	CbGeAlD
Acamprosate—GRIN2C—testis—testicular cancer	0.0038	0.0943	CbGeAlD
Acamprosate—SLC36A1—gonad—testicular cancer	0.00362	0.0899	CbGeAlD
Acamprosate—GRIN2D—testis—testicular cancer	0.00353	0.0877	CbGeAlD
Acamprosate—GRIN3A—testis—testicular cancer	0.00332	0.0825	CbGeAlD
Acamprosate—SLC36A1—female gonad—testicular cancer	0.00294	0.073	CbGeAlD
Acamprosate—GRIN2A—testis—testicular cancer	0.00262	0.0652	CbGeAlD
Acamprosate—SLC36A1—testis—testicular cancer	0.00261	0.0648	CbGeAlD
Acamprosate—SLC36A1—lymph node—testicular cancer	0.00189	0.047	CbGeAlD
Acamprosate—GABRB3—gonad—testicular cancer	0.00176	0.0438	CbGeAlD
Acamprosate—GABRB3—testis—testicular cancer	0.00127	0.0315	CbGeAlD
Acamprosate—Constipation—Etoposide—testicular cancer	0.000768	0.0008	CcSEcCtD
Acamprosate—Pain—Etoposide—testicular cancer	0.000768	0.0008	CcSEcCtD
Acamprosate—Urinary tract infection—Epirubicin—testicular cancer	0.000767	0.000799	CcSEcCtD
Acamprosate—Haemoglobin—Methotrexate—testicular cancer	0.000761	0.000793	CcSEcCtD
Acamprosate—Haemorrhage—Methotrexate—testicular cancer	0.000757	0.000789	CcSEcCtD
Acamprosate—Hepatitis—Methotrexate—testicular cancer	0.000757	0.000789	CcSEcCtD
Acamprosate—Sweating—Epirubicin—testicular cancer	0.000757	0.000788	CcSEcCtD
Acamprosate—Pollakiuria—Doxorubicin—testicular cancer	0.000757	0.000788	CcSEcCtD
Acamprosate—Haematuria—Epirubicin—testicular cancer	0.000753	0.000784	CcSEcCtD
Acamprosate—Dizziness—Ifosfamide—testicular cancer	0.000752	0.000783	CcSEcCtD
Acamprosate—Pharyngitis—Methotrexate—testicular cancer	0.000751	0.000783	CcSEcCtD
Acamprosate—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000748	0.000779	CcSEcCtD
Acamprosate—Weight increased—Doxorubicin—testicular cancer	0.000745	0.000777	CcSEcCtD
Acamprosate—Epistaxis—Epirubicin—testicular cancer	0.000744	0.000776	CcSEcCtD
Acamprosate—Weight decreased—Doxorubicin—testicular cancer	0.000741	0.000772	CcSEcCtD
Acamprosate—Feeling abnormal—Etoposide—testicular cancer	0.00074	0.000771	CcSEcCtD
Acamprosate—Hyperglycaemia—Doxorubicin—testicular cancer	0.000739	0.00077	CcSEcCtD
Acamprosate—Nausea—Dactinomycin—testicular cancer	0.000737	0.000768	CcSEcCtD
Acamprosate—Pneumonia—Doxorubicin—testicular cancer	0.000735	0.000765	CcSEcCtD
Acamprosate—Gastrointestinal pain—Etoposide—testicular cancer	0.000734	0.000765	CcSEcCtD
Acamprosate—Visual impairment—Methotrexate—testicular cancer	0.00073	0.00076	CcSEcCtD
Acamprosate—Vomiting—Ifosfamide—testicular cancer	0.000723	0.000753	CcSEcCtD
Acamprosate—Hypersensitivity—Cisplatin—testicular cancer	0.000722	0.000752	CcSEcCtD
Acamprosate—Rash—Ifosfamide—testicular cancer	0.000717	0.000747	CcSEcCtD
Acamprosate—Dermatitis—Ifosfamide—testicular cancer	0.000716	0.000746	CcSEcCtD
Acamprosate—Urticaria—Etoposide—testicular cancer	0.000713	0.000743	CcSEcCtD
Acamprosate—Haemoglobin—Epirubicin—testicular cancer	0.000712	0.000742	CcSEcCtD
Acamprosate—Stomatitis—Doxorubicin—testicular cancer	0.000712	0.000742	CcSEcCtD
Acamprosate—Rhinitis—Epirubicin—testicular cancer	0.00071	0.00074	CcSEcCtD
Acamprosate—Abdominal pain—Etoposide—testicular cancer	0.00071	0.00074	CcSEcCtD
Acamprosate—Body temperature increased—Etoposide—testicular cancer	0.00071	0.00074	CcSEcCtD
Acamprosate—Urinary tract infection—Doxorubicin—testicular cancer	0.00071	0.00074	CcSEcCtD
Acamprosate—Haemorrhage—Epirubicin—testicular cancer	0.000709	0.000738	CcSEcCtD
Acamprosate—Hepatitis—Epirubicin—testicular cancer	0.000709	0.000738	CcSEcCtD
Acamprosate—Tinnitus—Methotrexate—testicular cancer	0.000706	0.000735	CcSEcCtD
Acamprosate—Hypoaesthesia—Epirubicin—testicular cancer	0.000705	0.000735	CcSEcCtD
Acamprosate—Asthenia—Cisplatin—testicular cancer	0.000703	0.000733	CcSEcCtD
Acamprosate—Pharyngitis—Epirubicin—testicular cancer	0.000703	0.000733	CcSEcCtD
Acamprosate—Sweating—Doxorubicin—testicular cancer	0.0007	0.000729	CcSEcCtD
Acamprosate—Oedema peripheral—Epirubicin—testicular cancer	0.000698	0.000727	CcSEcCtD
Acamprosate—Haematuria—Doxorubicin—testicular cancer	0.000696	0.000725	CcSEcCtD
Acamprosate—Epistaxis—Doxorubicin—testicular cancer	0.000689	0.000718	CcSEcCtD
Acamprosate—Immune system disorder—Methotrexate—testicular cancer	0.000684	0.000713	CcSEcCtD
Acamprosate—Visual impairment—Epirubicin—testicular cancer	0.000683	0.000711	CcSEcCtD
Acamprosate—Chills—Methotrexate—testicular cancer	0.000679	0.000708	CcSEcCtD
Acamprosate—Nausea—Ifosfamide—testicular cancer	0.000675	0.000704	CcSEcCtD
Acamprosate—Diarrhoea—Cisplatin—testicular cancer	0.000671	0.000699	CcSEcCtD
Acamprosate—Alopecia—Methotrexate—testicular cancer	0.000669	0.000697	CcSEcCtD
Acamprosate—Mental disorder—Methotrexate—testicular cancer	0.000663	0.000691	CcSEcCtD
Acamprosate—Hypersensitivity—Etoposide—testicular cancer	0.000662	0.000689	CcSEcCtD
Acamprosate—Tinnitus—Epirubicin—testicular cancer	0.000661	0.000688	CcSEcCtD
Acamprosate—Malnutrition—Methotrexate—testicular cancer	0.000659	0.000687	CcSEcCtD
Acamprosate—Haemoglobin—Doxorubicin—testicular cancer	0.000659	0.000687	CcSEcCtD
Acamprosate—Rhinitis—Doxorubicin—testicular cancer	0.000657	0.000685	CcSEcCtD
Acamprosate—Haemorrhage—Doxorubicin—testicular cancer	0.000656	0.000683	CcSEcCtD
Acamprosate—Hepatitis—Doxorubicin—testicular cancer	0.000656	0.000683	CcSEcCtD
Acamprosate—Hypoaesthesia—Doxorubicin—testicular cancer	0.000652	0.00068	CcSEcCtD
Acamprosate—Pharyngitis—Doxorubicin—testicular cancer	0.000651	0.000678	CcSEcCtD
Acamprosate—Oedema peripheral—Doxorubicin—testicular cancer	0.000646	0.000673	CcSEcCtD
Acamprosate—Dysgeusia—Methotrexate—testicular cancer	0.000645	0.000672	CcSEcCtD
Acamprosate—Asthenia—Etoposide—testicular cancer	0.000644	0.000671	CcSEcCtD
Acamprosate—Immune system disorder—Epirubicin—testicular cancer	0.00064	0.000667	CcSEcCtD
Acamprosate—Back pain—Methotrexate—testicular cancer	0.000638	0.000664	CcSEcCtD
Acamprosate—Chills—Epirubicin—testicular cancer	0.000636	0.000662	CcSEcCtD
Acamprosate—Pruritus—Etoposide—testicular cancer	0.000635	0.000662	CcSEcCtD
Acamprosate—Visual impairment—Doxorubicin—testicular cancer	0.000632	0.000658	CcSEcCtD
Acamprosate—Alopecia—Epirubicin—testicular cancer	0.000626	0.000652	CcSEcCtD
Acamprosate—Vomiting—Cisplatin—testicular cancer	0.000623	0.000649	CcSEcCtD
Acamprosate—Mental disorder—Epirubicin—testicular cancer	0.000621	0.000647	CcSEcCtD
Acamprosate—Rash—Cisplatin—testicular cancer	0.000618	0.000644	CcSEcCtD
Acamprosate—Dermatitis—Cisplatin—testicular cancer	0.000617	0.000643	CcSEcCtD
Acamprosate—Malnutrition—Epirubicin—testicular cancer	0.000617	0.000643	CcSEcCtD
Acamprosate—Diarrhoea—Etoposide—testicular cancer	0.000614	0.00064	CcSEcCtD
Acamprosate—Ill-defined disorder—Methotrexate—testicular cancer	0.000612	0.000637	CcSEcCtD
Acamprosate—Tinnitus—Doxorubicin—testicular cancer	0.000611	0.000637	CcSEcCtD
Acamprosate—Anaemia—Methotrexate—testicular cancer	0.000609	0.000635	CcSEcCtD
Acamprosate—Flatulence—Epirubicin—testicular cancer	0.000608	0.000633	CcSEcCtD
Acamprosate—Tension—Epirubicin—testicular cancer	0.000605	0.000631	CcSEcCtD
Acamprosate—Dysgeusia—Epirubicin—testicular cancer	0.000604	0.000629	CcSEcCtD
Acamprosate—Nervousness—Epirubicin—testicular cancer	0.000599	0.000624	CcSEcCtD
Acamprosate—Back pain—Epirubicin—testicular cancer	0.000597	0.000622	CcSEcCtD
Acamprosate—Malaise—Methotrexate—testicular cancer	0.000594	0.000619	CcSEcCtD
Acamprosate—Dizziness—Etoposide—testicular cancer	0.000594	0.000619	CcSEcCtD
Acamprosate—Muscle spasms—Epirubicin—testicular cancer	0.000593	0.000618	CcSEcCtD
Acamprosate—Immune system disorder—Doxorubicin—testicular cancer	0.000592	0.000617	CcSEcCtD
Acamprosate—Vertigo—Methotrexate—testicular cancer	0.000592	0.000617	CcSEcCtD
Acamprosate—Leukopenia—Methotrexate—testicular cancer	0.00059	0.000615	CcSEcCtD
Acamprosate—Chills—Doxorubicin—testicular cancer	0.000588	0.000613	CcSEcCtD
Acamprosate—Nausea—Cisplatin—testicular cancer	0.000582	0.000607	CcSEcCtD
Acamprosate—Alopecia—Doxorubicin—testicular cancer	0.000579	0.000604	CcSEcCtD
Acamprosate—Cough—Methotrexate—testicular cancer	0.000575	0.000599	CcSEcCtD
Acamprosate—Mental disorder—Doxorubicin—testicular cancer	0.000574	0.000598	CcSEcCtD
Acamprosate—Ill-defined disorder—Epirubicin—testicular cancer	0.000572	0.000596	CcSEcCtD
Acamprosate—Convulsion—Methotrexate—testicular cancer	0.000571	0.000595	CcSEcCtD
Acamprosate—Vomiting—Etoposide—testicular cancer	0.000571	0.000595	CcSEcCtD
Acamprosate—Malnutrition—Doxorubicin—testicular cancer	0.000571	0.000595	CcSEcCtD
Acamprosate—Anaemia—Epirubicin—testicular cancer	0.00057	0.000594	CcSEcCtD
Acamprosate—Agitation—Epirubicin—testicular cancer	0.000567	0.000591	CcSEcCtD
Acamprosate—Rash—Etoposide—testicular cancer	0.000566	0.00059	CcSEcCtD
Acamprosate—Dermatitis—Etoposide—testicular cancer	0.000566	0.000589	CcSEcCtD
Acamprosate—Headache—Etoposide—testicular cancer	0.000563	0.000586	CcSEcCtD
Acamprosate—Flatulence—Doxorubicin—testicular cancer	0.000562	0.000586	CcSEcCtD
Acamprosate—Arthralgia—Methotrexate—testicular cancer	0.000561	0.000585	CcSEcCtD
Acamprosate—Myalgia—Methotrexate—testicular cancer	0.000561	0.000585	CcSEcCtD
Acamprosate—Chest pain—Methotrexate—testicular cancer	0.000561	0.000585	CcSEcCtD
Acamprosate—Tension—Doxorubicin—testicular cancer	0.00056	0.000583	CcSEcCtD
Acamprosate—Dysgeusia—Doxorubicin—testicular cancer	0.000559	0.000582	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000557	0.000581	CcSEcCtD
Acamprosate—Malaise—Epirubicin—testicular cancer	0.000556	0.00058	CcSEcCtD
Acamprosate—Discomfort—Methotrexate—testicular cancer	0.000554	0.000578	CcSEcCtD
Acamprosate—Nervousness—Doxorubicin—testicular cancer	0.000554	0.000578	CcSEcCtD
Acamprosate—Vertigo—Epirubicin—testicular cancer	0.000554	0.000577	CcSEcCtD
Acamprosate—Syncope—Epirubicin—testicular cancer	0.000553	0.000576	CcSEcCtD
Acamprosate—Leukopenia—Epirubicin—testicular cancer	0.000552	0.000575	CcSEcCtD
Acamprosate—Back pain—Doxorubicin—testicular cancer	0.000552	0.000575	CcSEcCtD
Acamprosate—Muscle spasms—Doxorubicin—testicular cancer	0.000549	0.000572	CcSEcCtD
Acamprosate—Palpitations—Epirubicin—testicular cancer	0.000545	0.000568	CcSEcCtD
Acamprosate—Confusional state—Methotrexate—testicular cancer	0.000542	0.000565	CcSEcCtD
Acamprosate—Loss of consciousness—Epirubicin—testicular cancer	0.000542	0.000565	CcSEcCtD
Acamprosate—Cough—Epirubicin—testicular cancer	0.000538	0.000561	CcSEcCtD
Acamprosate—Anaphylactic shock—Methotrexate—testicular cancer	0.000538	0.00056	CcSEcCtD
Acamprosate—Convulsion—Epirubicin—testicular cancer	0.000534	0.000557	CcSEcCtD
Acamprosate—Infection—Methotrexate—testicular cancer	0.000534	0.000557	CcSEcCtD
Acamprosate—Nausea—Etoposide—testicular cancer	0.000533	0.000556	CcSEcCtD
Acamprosate—Hypertension—Epirubicin—testicular cancer	0.000533	0.000555	CcSEcCtD
Acamprosate—Ill-defined disorder—Doxorubicin—testicular cancer	0.00053	0.000552	CcSEcCtD
Acamprosate—Anaemia—Doxorubicin—testicular cancer	0.000527	0.00055	CcSEcCtD
Acamprosate—Thrombocytopenia—Methotrexate—testicular cancer	0.000527	0.000549	CcSEcCtD
Acamprosate—Myalgia—Epirubicin—testicular cancer	0.000525	0.000547	CcSEcCtD
Acamprosate—Chest pain—Epirubicin—testicular cancer	0.000525	0.000547	CcSEcCtD
Acamprosate—Arthralgia—Epirubicin—testicular cancer	0.000525	0.000547	CcSEcCtD
Acamprosate—Agitation—Doxorubicin—testicular cancer	0.000524	0.000546	CcSEcCtD
Acamprosate—Anxiety—Epirubicin—testicular cancer	0.000523	0.000545	CcSEcCtD
Acamprosate—Skin disorder—Methotrexate—testicular cancer	0.000522	0.000544	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000521	0.000543	CcSEcCtD
Acamprosate—Hyperhidrosis—Methotrexate—testicular cancer	0.00052	0.000542	CcSEcCtD
Acamprosate—Discomfort—Epirubicin—testicular cancer	0.000519	0.000541	CcSEcCtD
Acamprosate—Malaise—Doxorubicin—testicular cancer	0.000515	0.000536	CcSEcCtD
Acamprosate—Dry mouth—Epirubicin—testicular cancer	0.000514	0.000535	CcSEcCtD
Acamprosate—Vertigo—Doxorubicin—testicular cancer	0.000513	0.000534	CcSEcCtD
Acamprosate—Anorexia—Methotrexate—testicular cancer	0.000513	0.000534	CcSEcCtD
Acamprosate—Syncope—Doxorubicin—testicular cancer	0.000512	0.000533	CcSEcCtD
Acamprosate—Leukopenia—Doxorubicin—testicular cancer	0.000511	0.000532	CcSEcCtD
Acamprosate—Confusional state—Epirubicin—testicular cancer	0.000508	0.000529	CcSEcCtD
Acamprosate—Palpitations—Doxorubicin—testicular cancer	0.000504	0.000525	CcSEcCtD
Acamprosate—Anaphylactic shock—Epirubicin—testicular cancer	0.000503	0.000524	CcSEcCtD
Acamprosate—Hypotension—Methotrexate—testicular cancer	0.000503	0.000524	CcSEcCtD
Acamprosate—Loss of consciousness—Doxorubicin—testicular cancer	0.000502	0.000523	CcSEcCtD
Acamprosate—Infection—Epirubicin—testicular cancer	0.0005	0.000521	CcSEcCtD
Acamprosate—Cough—Doxorubicin—testicular cancer	0.000498	0.000519	CcSEcCtD
Acamprosate—Shock—Epirubicin—testicular cancer	0.000495	0.000516	CcSEcCtD
Acamprosate—Convulsion—Doxorubicin—testicular cancer	0.000494	0.000515	CcSEcCtD
Acamprosate—Thrombocytopenia—Epirubicin—testicular cancer	0.000493	0.000514	CcSEcCtD
Acamprosate—Hypertension—Doxorubicin—testicular cancer	0.000493	0.000513	CcSEcCtD
Acamprosate—Tachycardia—Epirubicin—testicular cancer	0.000491	0.000512	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.00049	0.000511	CcSEcCtD
Acamprosate—Skin disorder—Epirubicin—testicular cancer	0.000489	0.000509	CcSEcCtD
Acamprosate—Hyperhidrosis—Epirubicin—testicular cancer	0.000487	0.000507	CcSEcCtD
Acamprosate—Insomnia—Methotrexate—testicular cancer	0.000486	0.000507	CcSEcCtD
Acamprosate—Chest pain—Doxorubicin—testicular cancer	0.000486	0.000506	CcSEcCtD
Acamprosate—Arthralgia—Doxorubicin—testicular cancer	0.000486	0.000506	CcSEcCtD
Acamprosate—Myalgia—Doxorubicin—testicular cancer	0.000486	0.000506	CcSEcCtD
Acamprosate—Anxiety—Doxorubicin—testicular cancer	0.000484	0.000504	CcSEcCtD
Acamprosate—Paraesthesia—Methotrexate—testicular cancer	0.000483	0.000503	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000483	0.000503	CcSEcCtD
Acamprosate—Discomfort—Doxorubicin—testicular cancer	0.00048	0.0005	CcSEcCtD
Acamprosate—Anorexia—Epirubicin—testicular cancer	0.00048	0.0005	CcSEcCtD
Acamprosate—Dyspnoea—Methotrexate—testicular cancer	0.00048	0.0005	CcSEcCtD
Acamprosate—Somnolence—Methotrexate—testicular cancer	0.000478	0.000498	CcSEcCtD
Acamprosate—Dry mouth—Doxorubicin—testicular cancer	0.000475	0.000495	CcSEcCtD
Acamprosate—Dyspepsia—Methotrexate—testicular cancer	0.000473	0.000493	CcSEcCtD
Acamprosate—Hypotension—Epirubicin—testicular cancer	0.00047	0.00049	CcSEcCtD
Acamprosate—Confusional state—Doxorubicin—testicular cancer	0.00047	0.000489	CcSEcCtD
Acamprosate—Decreased appetite—Methotrexate—testicular cancer	0.000468	0.000487	CcSEcCtD
Acamprosate—Anaphylactic shock—Doxorubicin—testicular cancer	0.000466	0.000485	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000464	0.000484	CcSEcCtD
Acamprosate—Infection—Doxorubicin—testicular cancer	0.000463	0.000482	CcSEcCtD
Acamprosate—Pain—Methotrexate—testicular cancer	0.00046	0.000479	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000459	0.000478	CcSEcCtD
Acamprosate—Shock—Doxorubicin—testicular cancer	0.000458	0.000477	CcSEcCtD
Acamprosate—Thrombocytopenia—Doxorubicin—testicular cancer	0.000456	0.000475	CcSEcCtD
Acamprosate—Insomnia—Epirubicin—testicular cancer	0.000455	0.000474	CcSEcCtD
Acamprosate—Tachycardia—Doxorubicin—testicular cancer	0.000455	0.000474	CcSEcCtD
Acamprosate—Skin disorder—Doxorubicin—testicular cancer	0.000452	0.000471	CcSEcCtD
Acamprosate—Paraesthesia—Epirubicin—testicular cancer	0.000452	0.000471	CcSEcCtD
Acamprosate—Hyperhidrosis—Doxorubicin—testicular cancer	0.00045	0.000469	CcSEcCtD
Acamprosate—Dyspnoea—Epirubicin—testicular cancer	0.000449	0.000468	CcSEcCtD
Acamprosate—Somnolence—Epirubicin—testicular cancer	0.000448	0.000466	CcSEcCtD
Acamprosate—Anorexia—Doxorubicin—testicular cancer	0.000444	0.000463	CcSEcCtD
Acamprosate—Feeling abnormal—Methotrexate—testicular cancer	0.000443	0.000462	CcSEcCtD
Acamprosate—Dyspepsia—Epirubicin—testicular cancer	0.000443	0.000462	CcSEcCtD
Acamprosate—Gastrointestinal pain—Methotrexate—testicular cancer	0.00044	0.000458	CcSEcCtD
Acamprosate—Decreased appetite—Epirubicin—testicular cancer	0.000438	0.000456	CcSEcCtD
Acamprosate—Hypotension—Doxorubicin—testicular cancer	0.000435	0.000453	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000435	0.000453	CcSEcCtD
Acamprosate—Pain—Epirubicin—testicular cancer	0.00043	0.000448	CcSEcCtD
Acamprosate—Constipation—Epirubicin—testicular cancer	0.00043	0.000448	CcSEcCtD
Acamprosate—Urticaria—Methotrexate—testicular cancer	0.000427	0.000445	CcSEcCtD
Acamprosate—Abdominal pain—Methotrexate—testicular cancer	0.000425	0.000443	CcSEcCtD
Acamprosate—Body temperature increased—Methotrexate—testicular cancer	0.000425	0.000443	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000424	0.000442	CcSEcCtD
Acamprosate—Insomnia—Doxorubicin—testicular cancer	0.000421	0.000439	CcSEcCtD
Acamprosate—Paraesthesia—Doxorubicin—testicular cancer	0.000418	0.000436	CcSEcCtD
Acamprosate—Dyspnoea—Doxorubicin—testicular cancer	0.000415	0.000433	CcSEcCtD
Acamprosate—Feeling abnormal—Epirubicin—testicular cancer	0.000415	0.000432	CcSEcCtD
Acamprosate—Somnolence—Doxorubicin—testicular cancer	0.000414	0.000431	CcSEcCtD
Acamprosate—Gastrointestinal pain—Epirubicin—testicular cancer	0.000412	0.000429	CcSEcCtD
Acamprosate—Dyspepsia—Doxorubicin—testicular cancer	0.00041	0.000427	CcSEcCtD
Acamprosate—Decreased appetite—Doxorubicin—testicular cancer	0.000405	0.000422	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000402	0.000419	CcSEcCtD
Acamprosate—Urticaria—Epirubicin—testicular cancer	0.0004	0.000417	CcSEcCtD
Acamprosate—Pain—Doxorubicin—testicular cancer	0.000398	0.000415	CcSEcCtD
Acamprosate—Constipation—Doxorubicin—testicular cancer	0.000398	0.000415	CcSEcCtD
Acamprosate—Abdominal pain—Epirubicin—testicular cancer	0.000398	0.000415	CcSEcCtD
Acamprosate—Body temperature increased—Epirubicin—testicular cancer	0.000398	0.000415	CcSEcCtD
Acamprosate—Hypersensitivity—Methotrexate—testicular cancer	0.000396	0.000413	CcSEcCtD
Acamprosate—Asthenia—Methotrexate—testicular cancer	0.000386	0.000402	CcSEcCtD
Acamprosate—Feeling abnormal—Doxorubicin—testicular cancer	0.000384	0.0004	CcSEcCtD
Acamprosate—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000381	0.000397	CcSEcCtD
Acamprosate—Pruritus—Methotrexate—testicular cancer	0.000381	0.000397	CcSEcCtD
Acamprosate—Hypersensitivity—Epirubicin—testicular cancer	0.000371	0.000386	CcSEcCtD
Acamprosate—Urticaria—Doxorubicin—testicular cancer	0.00037	0.000386	CcSEcCtD
Acamprosate—Body temperature increased—Doxorubicin—testicular cancer	0.000368	0.000384	CcSEcCtD
Acamprosate—Abdominal pain—Doxorubicin—testicular cancer	0.000368	0.000384	CcSEcCtD
Acamprosate—Diarrhoea—Methotrexate—testicular cancer	0.000368	0.000383	CcSEcCtD
Acamprosate—Asthenia—Epirubicin—testicular cancer	0.000361	0.000376	CcSEcCtD
Acamprosate—Pruritus—Epirubicin—testicular cancer	0.000356	0.000371	CcSEcCtD
Acamprosate—Dizziness—Methotrexate—testicular cancer	0.000356	0.000371	CcSEcCtD
Acamprosate—Diarrhoea—Epirubicin—testicular cancer	0.000344	0.000359	CcSEcCtD
Acamprosate—Hypersensitivity—Doxorubicin—testicular cancer	0.000343	0.000358	CcSEcCtD
Acamprosate—Vomiting—Methotrexate—testicular cancer	0.000342	0.000356	CcSEcCtD
Acamprosate—Rash—Methotrexate—testicular cancer	0.000339	0.000353	CcSEcCtD
Acamprosate—Dermatitis—Methotrexate—testicular cancer	0.000339	0.000353	CcSEcCtD
Acamprosate—Headache—Methotrexate—testicular cancer	0.000337	0.000351	CcSEcCtD
Acamprosate—Asthenia—Doxorubicin—testicular cancer	0.000334	0.000348	CcSEcCtD
Acamprosate—Dizziness—Epirubicin—testicular cancer	0.000333	0.000347	CcSEcCtD
Acamprosate—Pruritus—Doxorubicin—testicular cancer	0.00033	0.000343	CcSEcCtD
Acamprosate—Vomiting—Epirubicin—testicular cancer	0.00032	0.000333	CcSEcCtD
Acamprosate—Nausea—Methotrexate—testicular cancer	0.000319	0.000333	CcSEcCtD
Acamprosate—Diarrhoea—Doxorubicin—testicular cancer	0.000319	0.000332	CcSEcCtD
Acamprosate—Rash—Epirubicin—testicular cancer	0.000317	0.000331	CcSEcCtD
Acamprosate—Dermatitis—Epirubicin—testicular cancer	0.000317	0.00033	CcSEcCtD
Acamprosate—Headache—Epirubicin—testicular cancer	0.000315	0.000329	CcSEcCtD
Acamprosate—Dizziness—Doxorubicin—testicular cancer	0.000308	0.000321	CcSEcCtD
Acamprosate—Nausea—Epirubicin—testicular cancer	0.000299	0.000312	CcSEcCtD
Acamprosate—Vomiting—Doxorubicin—testicular cancer	0.000296	0.000309	CcSEcCtD
Acamprosate—Rash—Doxorubicin—testicular cancer	0.000294	0.000306	CcSEcCtD
Acamprosate—Dermatitis—Doxorubicin—testicular cancer	0.000293	0.000306	CcSEcCtD
Acamprosate—Headache—Doxorubicin—testicular cancer	0.000292	0.000304	CcSEcCtD
Acamprosate—Nausea—Doxorubicin—testicular cancer	0.000277	0.000288	CcSEcCtD
